China is marching into stem cell era | 41820
Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

China is marching into stem cell era

11th World Congress on Cell & Tissue Science

May 09-10, 2018 Tokyo, Japan

Yijia Li

Yunnan Province Stem Cell Bank, China

Scientific Tracks Abstracts: J Cell Sci Ther

Abstract :

China holds the stem cell treatment which is the future and supports various basic and translational researches. In 2015, Central Government has three policies released and In March 2016 founded the Stem Cell Translational Committee with 33 Scientific members. June 2016, China approved 30 hospitals to carry out stem cell translational research and the final stem cell treatment will be using a new registration pathway. Dec 2017, second batch, 72 certified hospitals released. Therefore, open the gate of many stem cell clinical trials. Now stem cell development especially MSC development is moving very fast. It is estimated that in the next 3-5 years, China will approve several stem cell treatments and also support hundreds of translational research.

Biography :

Yijia Li has a Bachelor’s degree in Biology from Tsinghua University and double degree of Economics and Management from Peking University. After completing his PhD at Florey Institute of Neuroscience and Mental Health, he joined Shunxi-Monash University Joint Lab, participated and facilitated several translational projects with Monash University, University of Melbourne, RMIT, CSIRO, ARC and NHMRC. In 2015, he was appointed as the Director of Yunnan Province Stem Cell Bank (YSCB) and Yunnan Shunxi Stem Cell and Regenerative Medicine Research Center (SSRC). He leads several projects in MSC basic and translational research in both China and Australia and has translated several books into Chinese including 5th Edition of NetCord-FACT Cord Blood Accreditation Manual.